Published in Acta Derm Venereol on March 01, 2010
Late-onset disseminated superficial actinic porokeratosis in an elderly woman. Dermatol Ther (Heidelb) (2011) 0.78
A case of linear porokeratosis superimposed on disseminated superficial actinic porokeratosis. Case Rep Dermatol (2010) 0.75
Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood (2005) 2.55
Managing comorbid disease in patients with psoriasis. BMJ (2010) 1.89
KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment. J Natl Cancer Inst (2008) 1.72
Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J Invest Dermatol (2004) 1.70
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood (2010) 1.67
Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol (2008) 1.46
Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J (2012) 1.31
Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology (2002) 1.31
Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst (2003) 1.25
A role for caspase-1 in heart failure. Circ Res (2007) 1.13
8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol (2010) 1.13
Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J (2012) 1.10
Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol (2005) 1.10
The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr Med Chem (2007) 1.09
P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis. Expert Opin Ther Targets (2007) 1.06
Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol (2010) 0.99
Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One (2013) 0.99
Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? AJR Am J Roentgenol (2008) 0.98
Reliability of diagnosis of melanoma in situ. Lancet (2002) 0.96
NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways. J Invest Dermatol (2009) 0.95
Dendritic epidermal T cells (DETC) are diminished in integrin alphaE(CD103)-deficient mice. J Invest Dermatol (2002) 0.94
Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity. Proc Natl Acad Sci U S A (2013) 0.94
Successful Nd:YAG laser therapy for hair removal in the oral cavity after plastic reconstruction using hairy donor sites. Dermatology (2013) 0.93
Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro. Mol Immunol (2004) 0.93
Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. Am J Pathol (2011) 0.92
Melanoma arising in segmental nevus spilus: detection by sequential digital dermatoscopy. J Am Acad Dermatol (2009) 0.92
Methotrexate-induced toxic epidermal necrolysis-like skin toxicity. Eur J Dermatol (2007) 0.91
Integrin alpha E(CD103)beta 7 influences cellular shape and motility in a ligand-dependent fashion. Blood (2008) 0.90
Tumor necrosis factor antagonists in the therapy of psoriasis. Clin Dermatol (2008) 0.90
Inhibition of platelet GPIb alpha and promotion of melanoma metastasis. J Invest Dermatol (2009) 0.89
The dark side of beauty: acne fulminans induced by anabolic steroids in a male bodybuilder. Arch Dermatol (2012) 0.89
Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair. Exp Dermatol (2012) 0.88
Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription. J Invest Dermatol (2013) 0.88
Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin. J Antimicrob Chemother (2007) 0.88
Interfering with leukocyte rolling--a promising therapeutic approach in inflammatory skin disorders? Trends Pharmacol Sci (2003) 0.88
Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesis. J Invest Dermatol (2007) 0.88
Successful treatment of a large hemangioma with propranolol. J Dtsch Dermatol Ges (2009) 0.87
Animal models of psoriasis. Clin Dermatol (2007) 0.87
Adhesion maturation of neutrophils on nanoscopically presented platelet glycoprotein Ibα. ACS Nano (2013) 0.87
Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin. Immunology (2009) 0.87
PECAM-1 polymorphism affects monocyte adhesion to endothelial cells. Transplantation (2008) 0.86
Successful treatment of severe keratosis pilaris rubra with a 595-nm pulsed dye laser. Dermatol Surg (2009) 0.86
Recommendations for detection of individual risk for comorbidities in patients with psoriasis. Arch Dermatol Res (2013) 0.85
Expression of gp130 in tumors and inflammatory disorders of the skin: formal proof of its identity as CD146 (MUC18, Mel-CAM). J Invest Dermatol (2005) 0.85
The complex clinical picture of side effects to anticoagulation. Med Clin North Am (2010) 0.85
Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach? Exp Dermatol (2007) 0.85
Seven-point checklist for dermatoscopy: performance during 10 years of prospective surveillance of patients at increased melanoma risk. J Am Acad Dermatol (2010) 0.84
Cutaneous side effects of inhibition of VEGF signal transduction. J Dtsch Dermatol Ges (2009) 0.84
Impaired induction of adhesion molecule expression in immortalized endothelial cells leads to functional defects in dynamic interactions with lymphocytes. J Invest Dermatol (2007) 0.84
Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition. Exp Dermatol (2011) 0.84
Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus. J Clin Invest (2014) 0.84
Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes. Exp Dermatol (2013) 0.84
Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression. Exp Dermatol (2011) 0.84
Molecular biology of basal and squamous cell carcinomas. Adv Exp Med Biol (2014) 0.83
Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions. Exp Dermatol (2011) 0.83
Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations. Exp Dermatol (2012) 0.83
Perioral dermatitis. J Dtsch Dermatol Ges (2010) 0.82
Treatment of scabies with 5% permethrin cream: results of a German multicenter study. J Dtsch Dermatol Ges (2006) 0.82
PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions. J Invest Dermatol (2008) 0.82
No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study. Arch Dermatol Res (2012) 0.81
Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions. J Clin Invest (2010) 0.81
Multifocal capillary malformations due to RASA1 mutation misdiagnosed as cutaneous mastocytosis. Arch Dermatol (2012) 0.81
Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes. Cancer Immunol Immunother (2007) 0.81
Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. Haematologica (2007) 0.81
Intertriginous urticaria pigmentosa. Dermatology (2005) 0.81
To die or not to die, that's the question--and the answer may depend on netrin-1. J Natl Cancer Inst (2009) 0.80
Methemoglobinemia due to local anesthesia with low-dose prilocaine. Dermatol Surg (2008) 0.80
Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer. Arch Dermatol Res (2004) 0.80
Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells. Exp Dermatol (2009) 0.80
Anaphylaxis during treatment of nausea and vomiting: IgE-mediated metoclopramide allergy. Ann Pharmacother (2006) 0.80
Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGF beta 1 transgenic mice. Exp Dermatol (2010) 0.80
Diffuse melanosis in a patient with multifocal liver and thyroid metastases of a malignant melanoma. J Dtsch Dermatol Ges (2012) 0.80
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients. J Rheumatol (2015) 0.80
Nanoscale integrin ligand patterns determine melanoma cell behavior. ACS Nano (2014) 0.79
CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes. Exp Dermatol (2007) 0.79
Circular, nanostructured and biofunctionalized hydrogel microchannels for dynamic cell adhesion studies. Lab Chip (2012) 0.79
Assessment of melanoma histotypes and associated patient related factors: basis for a predictive statistical model. J Dtsch Dermatol Ges (2015) 0.79
Combination therapy of infantile hemangiomas with pulsed dye laser and Nd:YAG laser is effective and safe. J Dtsch Dermatol Ges (2014) 0.78
Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung. Exp Dermatol (2011) 0.78
Integrating static and dynamic features of melanoma: the DynaMel algorithm. J Am Acad Dermatol (2011) 0.78
Lymph node ultrasound during melanoma follow-up significantly improves metastasis detection compared with clinical examination alone: a study on 433 patients. Melanoma Res (2011) 0.78
8-Methoxypsoralen plus UVA treatment increases the proportion of CLA+ CD25+ CD4+ T cells in lymph nodes of K5.hTGFβ1 transgenic mice. Exp Dermatol (2012) 0.78
Photo quiz. A 32-year-old man with ulcerative mucositis, skin lesions, and nail dystrophy. Chronic mucocutaneous candidiasis by multidrug-resistant Candida albicans. Clin Infect Dis (2012) 0.77
Constitutive and functionally relevant expression of JAM-C on platelets. Thromb Haemost (2010) 0.77
Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor. Exp Dermatol (2012) 0.77
TNF α-induced leukocyte-endothelial cell interactions show marked interindividual differences independent of the clinical response to adalimumab. Exp Dermatol (2014) 0.77
Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection. Immunol Allergy Clin North Am (2009) 0.77
Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas. Exp Dermatol (2011) 0.77
Squamomelanocytic tumor of the nail unit metastasizing to a sentinel lymph node: a dermoscopic and histologic investigation. Dermatology (2012) 0.77